佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: APULA

【K1 0111 交流专区】企文科技

  [复制链接]
发表于 2-10-2022 04:58 PM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
Medical Device Authority ("MDA") of Malaysia Grants Approval To K-One MediTech Sdn Bhd To Distribute Silicone Adhesive Tape Primarily Used For Wound Care Dressing
1. Introduction

The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One MediTech Sdn Bhd (“K-One MediTech”) has on 27 September 2022 received approval from the Medical Device Authority (“MDA”) under the Ministry of Health, Malaysia to distribute and sell silicone adhesive tapes primarily used for wound care dressing. The K-One Group will sell the silicone adhesive tapes in Malaysia as an authorized representative of Wuhan Huawei Technology Co., Ltd (“WH Tech”) which is the manufacturer based in China.

2. About WH Tech & K-One MediTech

2.1   WH Tech

WH Tech, the developer and manufacturer of the silicone adhesive tapes is based in Wuhan, Hubei, China. It specializes in developing, manufacturing and marketing of various advanced wound dressings and other medical products. Since its establishment in 2002, WH Tech has been accorded with ISO 9001, ISO 13485, FDA and CE certifications.

2.2  K-One MediTech

K-One MediTech is a wholly-owned subsidiary of K-One Tech. It was incorporated in 2001. Its principal business and focus are in the development, manufacturing and supply of medical and healthcare products which includes medical devices, healthcare consumables, oral care gadgets and hospital equipment.

3.  Silicone Adhesive Tapes For Wound Care Applications & MDA Approval

The silicone adhesive tapes are advanced wound dressings which come in three product types. The first two product categories are applicable to a variety of indwelling catheters, electrodes or other external fixations that require gentle but robust skin protection and adhesion, while the third product type helps to improve scar appearance (including hypertrophic and keloid) and restores skin to a more natural color and texture. It also alleviates itchy skin and discomfort associated with scars.

MDA has approved the distribution and sale of the above silicone adhesive tapes in three product categories for a period of five years from 26 September 2022 to 25 September 2027.

The approval will provide the opportunity for the K-One Group to further expand its medical device business. The silicone adhesive tape wound dressing market is growing as its demand is anticipated to increase in tandem with the rising trend of surgeries performed in Malaysia (and abroad). Moreover, increasing awareness relating to the employment of medical tapes for securement among physicians and patients and the rising incidence of wounds, burns, injuries are anticipated to spice up the market demand.

4. Financial Effects

The approval will have immaterial impact on the net assets and gearing of K-One Tech for the financial year ending 31 December 2022. It will not have any effect on the issued and paid-up share capital and the substantial shareholders’ shareholding in K-One Tech.

With the distribution and marketing process anticipated to commence immediately and sales progressively scaling up in the coming years, it is expected to contribute positively to the earnings of K-One Tech for the financial years ending 31 December 2022 and beyond.

5. Risk Factors

The import and distribution of the said silicone adhesive tapes will be subjected to various risks which include supply chain disruptions, pricing changes, market demand volatility, competition and currency rates fluctuation. Notwithstanding, the K-One Group has established a successful track record in undertaking manufacturing and distribution of medical devices which would help in mitigating such risks.  

6. Approvals Required

The distribution and sales of the said silicone adhesive tapes for wound care dressing do not require approval from the shareholders of K-One Tech or relevant authorities except MDA which it has received the necessary approval.

7. Directors’ Statement

The Board of K-One Tech is of the opinion that the distribution and supply of the said silicone adhesive tapes primarily for wound care applications is in the best interest of the K-One Group after considering its potential and synergy to its existing healthcare business segment.

This announcement is dated 28 September 2022.




回复

使用道具 举报


ADVERTISEMENT

发表于 3-9-2023 10:15 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
MEDICAL DEVICE AUTHORITY (MDA) OF MALAYSIA GRANTS REGISTRATION APPROVAL TO K-ONE MEDITECH SDN BHD TO DISTRIBUTE DIVERSEY'S DISINFECTANT WIPES USED FOR CLEANING SURFACES AND EQUIPMENT
The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One MediTech Sdn Bhd (“K-One MediTech”) has on 30 August 2023 received approval from the Medical Device Authority (“MDA”) under the Ministry of Health, Malaysia for registration of Diversey’s Oxivir Excel disinfectant wipes (“wipes”) used for cleaning surfaces and equipment to be distributed in Malaysia. The K-One Group will sell the wipes in Malaysia as the exclusive distributor of Diversey (Malaysia) Sdn Bhd (“Diversey”).  

Please refer to the attachment for details of the announcement.

This announcement is dated 1 September 2023.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3382677

回复

使用道具 举报

发表于 2-4-2024 11:22 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
K-ONE TECHNOLOGY BERHAD ("K-ONE" OR THE "COMPANY")PROPOSED DIVERSIFICATION
On behalf of the Board of Directors of K-One ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announce that the Company intends to undertake the proposed diversification of the existing business of K-One and its subsidiaries ("K-One Group" or the "Group") to include the distribution and sale of healthcare products ("Healthcare Products Business") ("Proposed Diversification").

Further details of the Proposed Diversification are set out in the attachment.

This announcement is dated 1 April 2024.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3435433

回复

使用道具 举报

发表于 5-9-2024 11:41 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2024
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2024
30 Jun 2023
30 Jun 2024
30 Jun 2023
$$'000
$$'000
$$'000
$$'000
1Revenue
44,754
43,214
89,645
84,161
2Profit/(loss) before tax
1,219
366
3,518
138
3Profit/(loss) for the period
1,079
18
2,764
-407
4Profit/(loss) attributable to ordinary equity holders of the parent
1,008
18
2,831
-407
5Basic earnings/(loss) per share (Subunit)
0.12
0.00
0.34
-0.05
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.1434
0.1400

回复

使用道具 举报

发表于 5-10-2024 03:41 AM | 显示全部楼层
Type
Announcement
Subject
TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
RELATED PARTY TRANSACTIONS
Description
K-ONE TECHNOLOGY BERHAD ("K-ONE" OR "COMPANY")- PURCHASE OF FACTORY FROM LIM BENG FOOK/LIM SOON SENG BY K-ONE MEDITECH SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF K-ONE TECHNOLOGY BHD.
Pursuant to Rule 10.08(1) of the ACE Marketing Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of K-One Technology Bhd (“K-One” or “Company”) wishes to announce that its wholly-owned subsidiary, K-One MediTech Sdn. Bhd. (“K-One MediTech”) has on 4 October 2024 entered into a Sale and Purchase Agreement (“SPA”) with related parties, namely Lim Beng Fook and Lim Soon Seng for the purchase of a piece of leasehold land together with a one (1) unit of two (2) storey detached factory erected thereon bearing postal address 68, Lengkok Rishah 2, Kawasan Perindustrian Silibin, 30100 Ipoh, Perak for a total consideration of RM3,000,000.00 ("the Purchase"). The Purchase is a related party transaction as Lim Beng Fook and Lim Soon Seng who are the Executive Chairman and CEO of K-One respectively are the related parties and are interested in the Purchase.

Please refer to the attachment for further details.

This announcement is dated 4 October 2024.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3489310

回复

使用道具 举报

发表于 13-2-2025 10:38 PM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
K-ONE TECHNOLOGY BERHAD- MR GLOBAL (HK) LIMITED ("MINDRAY") APPOINTS K-ONE WELLNESS SDN BHD AS NON-EXCLUSIVE DISTRIBUTOR TO DISTRIBUTE ITS AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS) IN MALAYSIA.
The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One Wellness Sdn Bhd has entered into a Distribution and Supply Agreement with MR Global (HK) Limited (“Mindray”) to distribute on a non-exclusive basis the latter’s automated external defibrillators (“AEDs”) for the public (non-hospital) sector in Malaysia which was signed and noted on 12 February 2025.

Please refer to the attachment for details.

This announcement is dated 13 February 2025.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3523155

回复

使用道具 举报

Follow Us
发表于 1-3-2025 03:18 PM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2024
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2024
31 Dec 2023
31 Dec 2024
31 Dec 2023
MYR'000
MYR'000
MYR'000
MYR'000
1Revenue
54,056
40,635
201,724
167,250
2Profit/(loss) before tax
-934
1,772
1,872
148
3Profit/(loss) for the period
-857
2,587
619
232
4Profit/(loss) attributable to ordinary equity holders of the parent
-591
2,739
201
350
5Basic earnings/(loss) per share (Subunit)
-0.07
0.33
0.02
0.04
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent
0.1401
0.1400

回复

使用道具 举报

发表于 28-3-2025 07:27 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
K-ONE TECHNOLOGY BERHAD- CIGA HEALTHCARE LTD, UK APPOINTS K-ONE WELLNESS SDN BHD AS EXCLUSIVE DISTRIBUTOR TO DISTRIBUTE ITS FERTILITY AND OTHER PRODUCT RANGE OF HEALTHCARE TEST KITS UNDER THE "SURESIGN" BRAND IN MALAYSIA.
The Board of Directors of K-One Technology Berhad (“K-One Tech” or “Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One Wellness Sdn Bhd (“K-One Wellness”) has on 27 March 2025 entered into a Distribution Agreement with CIGA Healthcare Ltd based in United Kingdom to distribute the latter’s product range of fertility and other healthcare test kits in Malaysia.

Please refer to the attachment for details.

This announcement is dated 27 March 2025.
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3539018

回复

使用道具 举报


ADVERTISEMENT

发表于 15-7-2025 01:26 AM | 显示全部楼层
K-ONE TECHNOLOGY BERHAD

Date of change
02 May 2025
Name
MR CHOI KENG MUN
Age
56
Gender
Male
Nationality
Malaysia
Type of change
Resignation
Designation
Others
Reason
Internal reorganization of Finance and Accounts function of K-One Group.
Details of any disagreement that he/she has with the Board of Directors
No
Whether there are any matters that need to be brought to the attention of shareholders
No
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
  


Remarks :
Mr Choi Keng Mun ceased as the Principal Officer of K-One Technology Berhad. However, he continues serving the K-One Group as Senior Finance Director, responsible for corporate finance and special functions. Ms Caris Lim Soh Choon, who is currently the Associate Finance Director, will replace him as the Principal Officer and head the Finance & Accounts function of the K-One Group.





Date of change
02 May 2025
Name
MISS LIM SOH CHOON
Age
43
Gender
Female
Nationality
Malaysia
Type of change
Appointment
Designation
Others
Qualifications
No
Qualifications
Major/Field of Study
Institute/University
Additional Information
1
Professional Qualification
Accounting
Association of Chartered Certified Accountants (ACCA)
Member
2
Professional Qualification
Accounting
Malaysian Institute of Accountants (MIA)
Member
  
Working experience and occupation
Ms Lim Soh Choon ("Ms Caris Lim") joined the K-One Group as Associate Finance Director in August 2024. Prior to that, she accumulated nearly 20 years of experience in audit, corporate governance, and financial management, having previously served with financial institutions and other private sector companies.
Directorships in public companies and listed issuers (if any)
NIL
Family relationship with any director and/or major shareholder of the listed issuer
NIL
Any conflict of interests that he/she has with the listed issuer
NIL
Details of any interest in the securities of the listed issuer or its subsidiaries
NIL


Remarks :
Ms Caris Lim holds the position of Associate Finance Director. She will be responsible for the K-One Group's operations finance which includes financial planning, accounts, budgeting, treasury, tax and other aspects of financial/accounts management.


回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 18-7-2025 05:25 PM , Processed in 0.128246 second(s), 22 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表